Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability (2015 - 2023)

Aytu Biopharma (AYTU) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $100000.0 in Q2 2023.

• On a quarterly basis, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $100000.0 in Q2 2023; TTM through Jun 2023 was $100000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $100000.0, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability for Q2 2023 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for AYTU reached as high as $200000.0 in Q2 2021 and fell as low as $100000.0 in Q3 2021.
• Historically, Non-Current Deferred Tax Liability has averaged $120000.0 across 3 years, with a median of $100000.0 in 2021.
• Across the five-year window, Non-Current Deferred Tax Liability slumped 50.0% in 2022 and changed 0.0% in 2023, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $100000.0 in Q2 2023, $100000.0 in Q2 2022, and $100000.0 in Q4 2021.